droperidol has been researched along with Cancer of the Urinary Tract in 1 studies
Droperidol: A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in conjunction with an opioid analgesic such as FENTANYL to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593)
droperidol : An organofluorine compound that is haloperidol in which the hydroxy group has been eliminated with the introduction of a double bond in the piperidine ring, and the 4-chlorophenyl group has been replaced by a benzimidazol-2-on-1-yl group. It is used in the management of chemotherapy-induced nausea and vomiting, and in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized cross-over study on the effects of methylprednisolone (MP), metoclopramide (MT) and droperidol (DP) on the control of nausea and vomiting associated with cis-platinum chemotherapy was performed." | 9.06 | [Randomized cross-over study on the effects of methylprednisolone, metoclopramide and droperidol on the control of nausea and vomiting associated with cis-platinum chemotherapy]. ( Akaza, H; Aso, Y; Fujita, K; Isurugi, K; Kawabe, K; Kinoshita, K; Koiso, K; Kondo, Y; Niijima, T; Yokoyama, M, 1986) |
| "A randomized cross-over study on the effects of methylprednisolone (MP), metoclopramide (MT) and droperidol (DP) on the control of nausea and vomiting associated with cis-platinum chemotherapy was performed." | 5.06 | [Randomized cross-over study on the effects of methylprednisolone, metoclopramide and droperidol on the control of nausea and vomiting associated with cis-platinum chemotherapy]. ( Akaza, H; Aso, Y; Fujita, K; Isurugi, K; Kawabe, K; Kinoshita, K; Koiso, K; Kondo, Y; Niijima, T; Yokoyama, M, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Niijima, T | 1 |
| Isurugi, K | 1 |
| Akaza, H | 1 |
| Kondo, Y | 1 |
| Kawabe, K | 1 |
| Fujita, K | 1 |
| Koiso, K | 1 |
| Yokoyama, M | 1 |
| Kinoshita, K | 1 |
| Aso, Y | 1 |
1 trial available for droperidol and Cancer of the Urinary Tract
| Article | Year |
|---|---|
[Randomized cross-over study on the effects of methylprednisolone, metoclopramide and droperidol on the control of nausea and vomiting associated with cis-platinum chemotherapy].
Topics: Adult; Aged; Cisplatin; Droperidol; Drug Administration Schedule; Female; Humans; Male; Methylpredni | 1986 |